| Value | ₹2.22 Cr |
|---|
BSE filing, BSE: 544139. Summary written from the filing by ALFA Finder's alert engine.
Koura Fine Diamond Jewelry Ltd: key numbers
- Share price
- ₹58.05
- Market cap
- ₹31.73 Cr
- Revenue (annual)
- ₹91.79 Cr
- Net profit (annual)
- ₹0.76 Cr
- P/E (TTM)
- 41.8×Sector 34.2×
- Promoter holding
- 66.86%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Koura Fine Diamond Jewelry Ltd
All →Koura Fine Diamond Jewelry Convertible Warrants
Soham Kamlesh Lodhiya, a promoter, acquired 2,15,000 equity shares of Koura Fine Diamond Jewelry Ltd upon the conversion of warrants.
Koura Fine Diamond Jewelry Preferential Issue
Soham Kamlesh Lodhiya, part of the promoter group, acquired 2,15,000 equity shares via preferential offer, increasing his stake from 4.77% to 8.04%.
- Value
- ₹0.67 Cr
Koura Fine Diamond Jewelry Management Change
Koura Fine Diamond Jewelry Limited has appointed Mr. Soham Kamlesh Lodhiya as Chief Financial Officer, replacing Ms. Charmi Kamlesh Lodhiya who resigned for career growth.
Koura Fine Diamond Jewelry Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31, reporting an increase in paid-up equity shares due to a prior allotment of 24,35,000 shares.
Koura Fine Diamond Jewelry Convertible Warrants
Promoter-director Kamlesh Lodhiya acquired 3.5 lakh warrants in a preferential offer valued at Rs. 0.32 Crore. Post-transaction stake stands at 4.76%.
- Value
- ₹0.32 Cr
- Promoter stake change
- +4.76%
Koura Fine Diamond Jewelry Board Meeting Date
Koura Fine Diamond Jewelry Limited scheduled a board meeting for October 19, 2026, to consider and approve its un-audited financial results.
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr